Has a company taken a peptide-conjugated oligonucleotide treatment to commercial market yet or is it still a fairly academic science ?
Hoping some posters with more of a medical science background can share their insight into the maturity of the technology .
Has a company taken a peptide-conjugated oligonucleotide...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $583.2M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 13.5¢ | 12.5¢ | $9.791K | 75.36K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 1284103 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 1150729 | 8 |
View Market Depth
| Last trade - 13.10pm 05/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |